Sunday, December 18, 2016

BRIEF-Brainstorm reaches agreement with FDA to proceed with NurOwn phase 3 trial

* Sees to commence an international phase 3 trial with

NurOwn in ALS in 2017

Read more
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)